Work

Supplementary Tables S1-3, Figure S1 from Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Tables S1-3, Figure S1. Table S1. Hypoxia increases signaling through JNK in colon cancer cell lines in a cell-specific manner Table S2. Hypoxia increases resistance to chemotherapy in colon cancer cell lines Table S3. Combination of the JNK inhibitor SP600125 with chemotherapy is synergistic in colon cancer cell lines Figure S1. Effects of oxaliplatin and SN-38 on JNK pathway in oxic conditions.

DOI: 10.1158/1078-0432.22457534.v1

Authors: Irina A. Vasilevskaya, Muthu Selvakumaran, Lucia Cabal Hierro, Sara R. Goldstein, Jeffrey D. Winkler, Peter J. O'Dwyer

Language: English

Topic: Cancer, Hypoxia, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361916361

Cites:

Cited by:

Related to: 10